SUVRETTA CAPITAL MANAGEMENT LLC
Q2 2022 Form 13-F
NEW YORK, NEW YORK
CIK 0001569064
· CRD 165153
· SEC-registered investment adviser
$2.6B Reported Value Total
MONTANOVA CAPITAL, LLC reports 12 total accounts under management (AUM). There are 12 discretionary accounts valued at $7,098,443,146, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Private funds (Form ADV)
5 funds
· $7.8B gross asset value
Hedge Fund: $7.8B · Venture Capital Fund: $7.4M
Source: Form ADV filed 2026-07-01
Reported value
$2.6B
Quarter over quarter
-14.5%
Holdings
89
Top-10 concentration
36.4%
Key People
Form ADV owners & control persons
Aaron Leonard Cowen
MANAGING MEMBER
Andrew Jon Nathanson
GENERAL COUNSEL & CHIEF COMPLIANCE OFFICER
Glenn Michael Shepard
CHIEF FINANCIAL OFFICER
Filing Navigation
13F Metrics
Loading 13F Metrics
Q2 2022 13F record
Q2 2022 13F filing summary
| Period of report | June 30, 2022 |
|---|---|
| Filed | August 15, 2022 |
| Form | 13F-HR |
| Reported value | $2.6B |
| Positions | 89 |
| Change in reported value | -19.7% |
| New positions | 23 |
| Exited positions | 21 |
| Position turnover | 40.0% |
| Top-10 concentration | 36.4% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q2 2026 13F
Filed Aug 14, 2026
|
95 | $5.5B |
|
Q1 2026 13F
Filed May 15, 2026
|
88 | $3.9B |
|
Q4 2025 13F
Filed Feb 17, 2026
|
90 | $4.9B |
|
Q3 2025 13F
Filed Nov 14, 2025
|
90 | $3.9B |
|
Q2 2025 13F
Filed Aug 14, 2025
|
95 | $3.3B |
|
Q1 2025 13F
Filed May 15, 2025
|
99 | $2.7B |
|
Q4 2024 13F
Filed Feb 14, 2025
|
94 | $2.9B |
|
Q3 2024 13F
Filed Nov 14, 2024
|
96 | $3.1B |
|
Q2 2024 13F
Filed Aug 14, 2024
|
97 | $2.7B |
|
Q1 2024 13F
Filed May 15, 2024
|
99 | $2.7B |
|
Q4 2023 13F
Filed Feb 14, 2024
|
87 | $2.2B |
|
Q3 2023 13F
Filed Nov 14, 2023
|
87 | $1.9B |
|
Q2 2023 13F
Filed Aug 14, 2023
|
100 | $1.9B |
|
Q1 2023 13F
Filed May 15, 2023
|
92 | $2.4B |
|
Q4 2022 13F
Filed Feb 14, 2023
|
89 | $2.4B |
|
Q3 2022 13F
Filed Nov 14, 2022
|
71 | $2.4B |
|
Q2 2022 13F
Filed Aug 15, 2022
|
89 | $2.6B |
|
Q1 2022 13F
Filed May 16, 2022
|
87 | $3.3B |
|
Q4 2021 13F
Filed Feb 14, 2022
|
94 | $5.2B |
|
Q3 2021 13F
Filed Nov 15, 2021
|
105 | $5.9B |
31 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q2 2022
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | RPRX ROYALTY PHARMA PLC | $129.4M | 4.92% |
| 2 | UNH UNITEDHEALTH GROUP INC | $123.8M | 4.71% |
| 3 | UNP UNION PAC CORP | $113.5M | 4.31% |
| 4 | LVS LAS VEGAS SANDS CORP | $97.5M | 3.71% |
| 5 | HUM HUMANA INC | $92.5M | 3.52% |
| 6 | OTIS OTIS WORLDWIDE CORP | $91.7M | 3.49% |
| 7 | IQV IQVIA HLDGS INC | $85.1M | 3.23% |
| 8 | ITCI INTRA-CELLULAR THERAPIES INC | $76.4M | 2.91% |
| 9 | EL LAUDER ESTEE COS INC | $74.6M | 2.84% |
| 10 | KURA KURA ONCOLOGY INC | $73.6M | 2.8% |
| 11 | TPR TAPESTRY INC | $68.6M | 2.61% |
| 12 | CNC CENTENE CORP DEL | $68.3M | 2.6% |
| 13 | MA MASTERCARD INCORPORATED | $66.0M | 2.51% |
| 14 | TMO THERMO FISHER SCIENTIFIC INC | $65.9M | 2.51% |
| 15 | MSFT MICROSOFT CORP | $64.2M | 2.44% |
| 16 | V VISA INC | $64.0M | 2.43% |
| 17 | MRTX MIRATI THERAPEUTICS INC | $63.9M | 2.43% |
| 18 | DHR DANAHER CORPORATION | $55.3M | 2.1% |
| 19 | AGIO AGIOS PHARMACEUTICALS INC | $51.5M | 1.96% |
| 20 | ACLX ARCELLX INC | $44.7M | 1.7% |
Values as reported on the Q2 2022 Form 13F. Every position is in the holdings table below.